Pfenex grants protein production rights to Merck
Protein production company Pfenex has granted Merck exclusive worldwide rights to its Pfenex Expression Technology for use in the development of a new undisclosed vaccine.
- In Vitro Diagnostics
- Research, Analytical Equipment & Supplies
- Drug Discovery Technologies
- Large Molecule
- Synthesis Technologies, Production Processes
- Includes Royalty or Profit Split Information
- R&D and Marketing (Licensing)
Please contact Sales at: (212) 520-2765 or email [email protected]
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.